These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Serum level of digoxin-like immunoreactive substances in newborn infants in the first two weeks of life, in umbilical cord blood and in pregnant patients at the time of labor]. Gawaz MP; Schreiber R; Vogt W; Genz T; Kellner M Klin Padiatr; 1990; 202(1):31-6. PubMed ID: 2156105 [TBL] [Abstract][Full Text] [Related]
4. Digoxin-like-immunoreactive substance: non-specific interference or a new hormone? Clerico A; Ghione S; Balzan S; Del Chicca MG J Nucl Med Allied Sci; 1984; 28(4):297-301. PubMed ID: 6100187 [No Abstract] [Full Text] [Related]
5. Digoxin-like immunoreactive substance in fetuses with and without cardiac pathology. Weiner CP; Landas S; Persoon TJ Am J Obstet Gynecol; 1987 Aug; 157(2):368-71. PubMed ID: 3618686 [TBL] [Abstract][Full Text] [Related]
11. A comparison of endogenous digoxin-like immunoreactivity and sodium transport inhibitory activity in umbilical arterial and venous serum. Morris JF; Poston L; Wolfe CD; Hilton PJ Clin Sci (Lond); 1988 Dec; 75(6):577-9. PubMed ID: 2850130 [TBL] [Abstract][Full Text] [Related]
12. Atrial natriuretic factor, digoxin-like immunoreactive substance, norepinephrine, epinephrine, and plasma renin activity in human fetuses and their alteration by fetal disease. Weiner CP; Robillard JE Am J Obstet Gynecol; 1988 Dec; 159(6):1353-60. PubMed ID: 2974684 [TBL] [Abstract][Full Text] [Related]
13. Digoxin-like immunoreactive substance in sera from umbilical cord, infants and mothers. Chen MR; Wu WH; Sung TC; Chen PN; Wang EY; Yang YC Taiwan Yi Xue Hui Za Zhi; 1987 Sep; 86(9):952-6. PubMed ID: 3694167 [No Abstract] [Full Text] [Related]
14. Peripartum changes in free and protein-bound digoxinlike immunoreactive factor. Jakobi P; Kol S; Weissman A; Krivoy N J Reprod Med; 1992 Feb; 37(2):127-9. PubMed ID: 1538354 [TBL] [Abstract][Full Text] [Related]
15. Fetal endoxins and complications of pregnancy. Goodlin RC; Makowski EL West J Med; 1988 May; 148(5):590-2. PubMed ID: 2845675 [TBL] [Abstract][Full Text] [Related]
16. A study into the nature and organ source of digoxin-like immunoreactive substance(s) in the perinatal period. Seccombe DW; Pudek MR; Humphries KH; Matthewson B; Taylor GP; Jacobson BE; Whitfield MP Biol Neonate; 1989; 56(3):136-46. PubMed ID: 2553137 [TBL] [Abstract][Full Text] [Related]
17. [The significance of digoxin-like immunoreactive factor (DLIF) for intensive care medicine]. Simon HB; Behrendt W; Stein T Anasth Intensivther Notfallmed; 1990 Jun; 25(3):235-6. PubMed ID: 2168132 [TBL] [Abstract][Full Text] [Related]
18. Digoxin-like immunoreactive factor in twin and pregnancy-associated hypertensive pregnancies. Jakobi P; Krivoy N; Weissman A; Paldi E Obstet Gynecol; 1989 Jul; 74(1):29-33. PubMed ID: 2733937 [TBL] [Abstract][Full Text] [Related]
19. Natriuretic activity of digoxin-like immunoreactive substance extracted from cord blood. Ebara H; Suzuki S; Nagashima K; Kuroume T Life Sci; 1988; 42(3):303-9. PubMed ID: 2826960 [TBL] [Abstract][Full Text] [Related]
20. Digoxin-like immunoreactive substances in urine and serum from preterm and term infants: relationship to renal excretion of sodium. Ebara H; Suzuki S; Nagashima K; Shimano S; Kuroume T J Pediatr; 1986 May; 108(5 Pt 1):760-2. PubMed ID: 3009770 [No Abstract] [Full Text] [Related] [Next] [New Search]